Nurix Therapeutics (NRIX) EBITDA Margin (2019 - 2026)
Nurix Therapeutics (NRIX) reported EBITDA Margin of 83.44% for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 1215.40 percentage points from -1131.96% a year earlier and up 1100.24 percentage points from the prior quarter.
Nurix Therapeutics (NRIX) EBITDA Margin (2019 - 2026) Analysis & Trends
Over the twelve months ended Aug 31, 2026, Nurix Therapeutics' EBITDA Margin came in at 42.51%, up 350.87 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it was -329.75%, up 43.69 percentage points from FY2024.
- EBITDA Margin has a five-year change of +22.57 percentage points (FY2020 to FY2025).
- By fiscal year, EBITDA Margin came in at -373.44% in FY2024 (-181.81 pp), -191.63% in FY2023 (+270.53 pp), -462.16% in FY2022 (-75.31 pp) and -386.84% in FY2021 (-34.53 pp).
- The fiscal Q3 2026 figure ranks as the highest quarterly EBITDA Margin in data going back to fiscal Q3 2019.
- Year over year, EBITDA Margin gained in two of the last eight quarters, with an average year-over-year change of -203.81 percentage points.
- The high point for year-over-year EBITDA Margin in five years was fiscal Q3 2026 (a gain of 1215.40 percentage points); the low point was fiscal Q1 2026 (a drop of 1116.39 percentage points).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -1016.80% (Q2 2026), -1444.32% (Q1 2026) and -596.41% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 83.44% |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 83.44% |
| May 31, 2026 | -1,016.80% |
| Feb 28, 2026 | -1,444.32% |
| Nov 30, 2025 | -596.41% |
| Aug 31, 2025 | -1,131.96% |
| May 31, 2025 | -104.59% |
| Feb 28, 2025 | -327.94% |
| Nov 30, 2024 | -467.54% |
| Aug 31, 2024 | -414.82% |
| May 31, 2024 | -382.15% |
| Feb 29, 2024 | -260.32% |
| Nov 30, 2023 | -286.30% |
| Aug 31, 2023 | -206.10% |
| May 31, 2023 | -81.07% |
| Feb 28, 2023 | -324.79% |
| Nov 30, 2022 | -693.96% |
| Aug 31, 2022 | -419.03% |
| May 31, 2022 | -388.51% |
| Feb 28, 2022 | -433.98% |
| Nov 30, 2021 | -502.79% |
Nurix Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();